Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A critical analysis of testosterone supplementation therapy and cardiovascular risk in elderly men.

Literature DB >> 24940464

A critical analysis of testosterone supplementation therapy and cardiovascular risk in elderly men.

Jason Scovell¹, Ranjith Ramasamy¹, Jason R Kovac².

Abstract

Entities: Chemical Species

Year: 2014 PMID： 24940464 PMCID： PMC4039601 DOI： 10.5489/cuaj.1962

Source DB: PubMed Journal: Can Urol Assoc J ISSN： 1911-6470 Impact factor: 1.862

× No keyword cloud information.

31 in total

1. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

Authors: Christina Wang; Glenn Cunningham; Adrian Dobs; Ali Iranmanesh; Alvin M Matsumoto; Peter J Snyder; Thomas Weber; Nancy Berman; Laura Hull; Ronald S Swerdloff
Journal: J Clin Endocrinol Metab Date: 2004-05 Impact factor: 5.958

2. Identification of late-onset hypogonadism in middle-aged and elderly men.

Authors: Frederick C W Wu; Abdelouahid Tajar; Jennifer M Beynon; Stephen R Pye; Alan J Silman; Joseph D Finn; Terence W O'Neill; Gyorgy Bartfai; Felipe F Casanueva; Gianni Forti; Aleksander Giwercman; Thang S Han; Krzysztof Kula; Michael E J Lean; Neil Pendleton; Margus Punab; Steven Boonen; Dirk Vanderschueren; Fernand Labrie; Ilpo T Huhtaniemi
Journal: N Engl J Med Date: 2010-06-16 Impact factor: 91.245

3. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging.

Authors: S M Harman; E J Metter; J D Tobin; J Pearson; M R Blackman
Journal: J Clin Endocrinol Metab Date: 2001-02 Impact factor: 5.958

4. Effects of graded doses of testosterone on erythropoiesis in healthy young and older men.

Authors: Andrea D Coviello; Beth Kaplan; Kishore M Lakshman; Tai Chen; Atam B Singh; Shalender Bhasin
Journal: J Clin Endocrinol Metab Date: 2007-12-26 Impact factor: 5.958

5. Trends in androgen prescribing in the United States, 2001 to 2011.

Authors: Jacques Baillargeon; Randall J Urban; Kenneth J Ottenbacher; Karen S Pierson; James S Goodwin
Journal: JAMA Intern Med Date: 2013-08-12 Impact factor: 21.873

6. Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST study.

Authors: Geoffrey Hackett; Nigel Cole; Mithun Bhartia; David Kennedy; Jessie Raju; Peter Wilkinson
Journal: J Sex Med Date: 2013-12-06 Impact factor: 3.802

7. Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men.

Authors: William D Finkle; Sander Greenland; Gregory K Ridgeway; John L Adams; Melissa A Frasco; Michael B Cook; Joseph F Fraumeni; Robert N Hoover
Journal: PLoS One Date: 2014-01-29 Impact factor: 3.240

Review 8. Welcoming low testosterone as a cardiovascular risk factor.

Authors: M Maggio; S Basaria
Journal: Int J Impot Res Date: 2009-06-18 Impact factor: 2.896

9. Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials.

Authors: Lin Xu; Guy Freeman; Benjamin J Cowling; C Mary Schooling
Journal: BMC Med Date: 2013-04-18 Impact factor: 8.775